Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.360
-0.020 (-0.59%)
At close: Nov 17, 2025, 4:00 PM EST
3.250
-0.110 (-3.27%)
After-hours: Nov 17, 2025, 5:41 PM EST
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $37.8 million as of November 17, 2025. Its market cap has increased by 7.72% in one year.
Market Cap
37.80M
Enterprise Value
25.53M
1-Year Change
7.72%
Ranking
Category
Stock Price
$3.36
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $37.80M, an increase of 24.64%. That is a compound annual growth rate of 4.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 37.80M | 9.88% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |